Crossmark

Applying integrated transcriptome and single-cell sequencing analysis to develop a prognostic signature based on M2-like tumor-associated macrophages for breast cancer

Crossref DOI link: https://doi.org/10.1007/s12672-025-02161-7

Published Online: 2025-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Yanghaochen

Lin, Peiyan

Zhu, Ye

Zhang, Qing

Zhou, Jinhong
License Information

Text and Data Mining valid from 2025-03-25

Version of Record valid from 2025-03-25
More Information

Article History

Received: 7 November 2024

Accepted: 17 March 2025

First Online: 25 March 2025

Declarations

:

: This manuscript is not a clinical trial, hence the ethics approval and Consent to participation are not applicable.

: The authors have no relevant financial or non-financial interests to disclose.

: Not applicable.

Document is current

Any future updates will be listed below